AS
Amit Sachdev (EVP Chief Patient & Ext Af Off) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $27.5M of VRTX (58,613 sh across 8 lots, as filed), executed Feb 19. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$28.4M
shares × price, as filed
Last traded
Feb 25
Filed Feb 26
Median ADV $756.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $28.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
VRTX
Vertex Pharmaceuticals Incorporated
VRTX · 0 buys · 2 sells
2 filings
Recent filings
VRTXSALE
Vertex Pharmaceuticals Incorporated
View filing →
$898K1,846 sh × $486.35
Exec Feb 25
Filed Feb 26 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $27.5M
58,613 sh across 8 lots
Exec Feb 19
Filed Feb 23 · 5:30 PM ET